Open Access. Powered by Scholars. Published by Universities.®

Biochemistry, Biophysics, and Structural Biology Commons

Open Access. Powered by Scholars. Published by Universities.®

Retrospective Theses and Dissertations

Microbiology

Veterinary microbiology and preventive medicine

Articles 1 - 8 of 8

Full-Text Articles in Biochemistry, Biophysics, and Structural Biology

Genetic Profiling Of Mycoplasma Hyopneumoniae , Melissa L. Madsen Jan 2005

Genetic Profiling Of Mycoplasma Hyopneumoniae , Melissa L. Madsen

Retrospective Theses and Dissertations

A microarray was constructed and applied to transcriptional profiling and genetic variation studies of Mycoplasma hyopneumoniae. The genome sequence enabled the construction of the microarray to allow a global approach to understanding fundamental processes in M. hyopneumoniae . These studies focused on whether M. hyopneumoniae regulates its genes under different environmental conditions and if genetic changes can be correlated with virulence. The microarray consisted of 632 open reading frames represented by polymerase chain reaction products and were used in a two-color experimental design. Data were analyzed using a mixed linear statistical model. Unique features implemented in these studies included the printing ...


Investigation Of Microcin 24 For Applications In Food Safety, Mechanism Of Resistance And Effect On Activity After Site-Directed Mutagenesis , Timothy Steven Frana Jan 2004

Investigation Of Microcin 24 For Applications In Food Safety, Mechanism Of Resistance And Effect On Activity After Site-Directed Mutagenesis , Timothy Steven Frana

Retrospective Theses and Dissertations

Microcin 24 is an antimicrobial peptide produced by Escherichia coli with activity against Salmonella typhimurium. In this study microcin 24 was investigated for its potential use in food safety, resistance development, and structure-activity relationship following site-directed mutagenesis. An attempt was made to produce microcin 24 from lactic acid bacteria by substituting the natural, dedicated leader peptide microcin-producing gene with a signal leader from divergicin A, which accesses the general secretion pathway. RNA sequences could be recovered from Carnobacterium divergens harboring an expression vector with the fusion construct, but no microcin activity could be detected. Concurrently, development and mechanism of resistance ...


Genetic And Phenotypic Variation Of The Equine Infectious Anemia Virus Surface Unit Envelope Glycoprotein During Disease Progression , Brett Alan Sponseller Jan 2003

Genetic And Phenotypic Variation Of The Equine Infectious Anemia Virus Surface Unit Envelope Glycoprotein During Disease Progression , Brett Alan Sponseller

Retrospective Theses and Dissertations

Lentiviruses are single-stranded RNA viruses generally associated with chronic diseases of the immune and central nervous systems. In contrast to the insidious, progressive nature of most lentiviral diseases, equine infectious anemia virus (EIAV) infection results in rapid onset of a variable disease course in equids. Acute disease is accompanied with high-titered viremia, thrombocytopenia, fever, depression, and inappetance. The chronic stage is usually characterized by recurrent episodes of disease. Equids that survive recurrent disease episodes progress to the inapparent stage of disease where no clinical signs are evident; however, there is persistent, ongoing virus replication. Lentiviruses exist within the host as ...


The Role Of Rev-Sr Protein Interactions In The Regulation Of Equine Infectious Anemia Virus Replication , Gregory Saang Park Jan 2003

The Role Of Rev-Sr Protein Interactions In The Regulation Of Equine Infectious Anemia Virus Replication , Gregory Saang Park

Retrospective Theses and Dissertations

Equine infectious anemia virus (EIAV) is a member of the lentivirus subfamily of retroviruses that produces a variable clinical disease course characterized as acute, chronic, and inapparent. The clinical signs can vary according to the stage of disease, and generally correlate with levels of virus replication. As with other retroviruses, EIAV utilizes both RNA and proteins to produce alternatively spliced transcripts required for virus replication. EIAV encodes a protein called Rev, which functions by binding unspliced and singly spliced viral mRNAs in the nucleus at a sequence called the Rev responsive element (RRE) and exporting them into the cytoplasm. Rev ...


Phospholipase C Of Clostridium Hemolyticum: Gene Characterization And Proof Of Its Role As A Protective Immunogen In Guinea Pigs , Paul Joseph Hauer Jan 2001

Phospholipase C Of Clostridium Hemolyticum: Gene Characterization And Proof Of Its Role As A Protective Immunogen In Guinea Pigs , Paul Joseph Hauer

Retrospective Theses and Dissertations

The phospholipase C (PLPC) gene from Clostridium hemolyticum was cloned using the polymerase chain reaction. An open reading frame which encodes a 399-amino acid protein, containing a 27-amino acid signal sequence, was identified. The molecular weight of the active protein was 42,869 daltons. A 16-amino acid N-terminal sequence determined by Edman degradation exactly matched the putative amino acid sequence of the gene product. Comparison of the nucleotide and amino acid sequences with Genebank databases demonstrated that the beta toxin of C. hemolyticum exhibits high homology with other bacterial PLPCs. The N-terminal portion of the beta toxin contains the zinc-binding ...


Bacteriophage Therapy: A Novel Method Of Lytic Phage Delivery , Ratree Platt Jan 2000

Bacteriophage Therapy: A Novel Method Of Lytic Phage Delivery , Ratree Platt

Retrospective Theses and Dissertations

The widespread emergence of multi-antibiotic resistant bacteria has increased the need for alternatives to conventional antibiotic therapy. Accordingly, a significant amount of effort has been made to investigate the potential use of bacteriophages as prophylactic and therapeutic agents for bacterial infections. In this study, molecular biological techniques were applied to construct a lysogen of lytic bacteriophage lambda in an attempt to combat with multi-antibiotic resistant bacteria by a novel method of lytic phage delivery;To accomplish this goal, two plasmid-based site-specific recombination (SSR) systems for integration and recovery of DNA constructs from Escherichia coli and Salmonella typhimurium chromosomes were developed ...


Evaluation Of Mycobacterial Esat-6 As A Type-I Immune Enhancing Adjuvant , Sreekumar Ambalakkat Menon Jan 1999

Evaluation Of Mycobacterial Esat-6 As A Type-I Immune Enhancing Adjuvant , Sreekumar Ambalakkat Menon

Retrospective Theses and Dissertations

The need for improved adjuvants has continued in spite of new vaccination strategies using recombinant proteins and genetic (DNA vectored) vaccines. The Mycobacterium tuberculosis protein ESAT-6 has been shown in mice to be involved in the recall of long-lived immunity and protection in mice against tuberculosis. Thus, this protein could potentially act as a molecular adjuvant enhancing antigen-specific Type I immune responses. This study examined the hypothesis that Es could enhance Type I responses against a second antigen in mice when presented as a fusion with that antigen. This was tested using ESAT-6 fusions with two Mycoplasma hyopneumoniae surface antigens ...


Genetic And Molecular Characterization Of The Rev Protein Of Equine Infectious Anemia Virus , Michael Andrew Belshan Jan 1999

Genetic And Molecular Characterization Of The Rev Protein Of Equine Infectious Anemia Virus , Michael Andrew Belshan

Retrospective Theses and Dissertations

Members of the lentivirus subfamily of retroviruses are characterized as causing slow, chronic disease. Atypical of other lentiviruses, such as human immunodeficiency virus type 1, equine infectious anemia virus (EIAV) may produce a rapid, variable disease course in horses. Infected horses may undergo an, acute episode of disease involving viremia, fever, and thrombocytopenia. Following this acute period, horses may resolve to an inapparent infection or suffer a chronic period of additional cycles of viremia, fever, and thrombocytopenia. Horses which survive clinical episodes usually become inapparent carriers of the virus for life. Numerous virus and host factors contribute to the phenotypic ...